Wegovy (semaglutide) is a medication commonly used for the treatment of obesity. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. Understanding how Wegovy works involves delving into its metabolic pathways and the role of the GLP-1 receptor in the body.
After subcutaneous injection, semaglutide is slowly absorbed into the bloodstream. Its slow absorption rate allows for a prolonged effect, making it suitable for once-weekly dosing.
Semaglutide is metabolised primarily in the liver. It undergoes enzymatic breakdown into smaller peptides and amino acids, which are then excreted through the kidneys.
The half-life of semaglutide is approximately one week, which is significantly longer than other GLP-1 receptor agonists. This long half-life contributes to its extended duration of action.
Wegovy works by mimicking a hormone in the body that regulates appetite. It binds to receptors in the brain that control hunger, making you feel fuller for longer. This helps to reduce calorie intake and, consequently, aids in weight loss.
The GLP-1 receptor plays a crucial role in regulating blood sugar levels. When semaglutide binds to this receptor, it stimulates the pancreas to release insulin in response to elevated blood glucose levels.
Another important function of the GLP-1 receptor is appetite regulation. Activation of this receptor sends signals to the brain, leading to a feeling of fullness and reduced food intake.
Some studies suggest that activation of the GLP-1 receptor may also have cardiovascular benefits, although more research is needed in this area.
Wegovy (semaglutide) is a potent GLP-1 receptor agonist that has shown promise in the treatment of obesity. Its unique metabolic profile and the critical role of the GLP-1 receptor in its mechanism of action make it a valuable addition to existing treatment options. Always consult healthcare professionals for medical advice.
Additional Resources
Why Buy Wegovy in the UK for Weight Loss?
The Lifespan of a Wegovy Pen: What You Should Know
Instructions for Using Wegovy Injection Pens Safely
How to Pair Your Diet with Wegovy (Semaglutide)?
What You Should Know About Wegovy Injection Side Effects?
The Sustainability of Long-Term Semaglutide Use
When to Expect Results from Semaglutide
Wegovy (Semaglutide) Pen Storage Instructions
Understanding NHS Weight Loss Injection Options
Sources
NICE, 2021. NICE recommends new drug for people living with obesity.
Novomedlink, 2021. Wegovy® STEP 1 Clinical Trial Results.
Novomedlink, 2021. Wegovy® STEP 4 Clinical Trial Results.
BMJ, 2021. Wegovy (semaglutide): a new weight loss drug for chronic weight management.
Wegovy, 2021. Weight-Loss Prescription Medication | Wegovy™ (semaglutide) Injection 2.4 mg.
PubMed, 2021. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
© 2013 - 2024 Al Muhsineen Limited. All Rights Reserved. Registered Pharmacy: 34 Halliwell Road, Bolton BL1 8RL. Registered Office: 254 First Floor, Shearbrow, Blackburn, England, BB1 8DS